EFFECT OF POSTURE ON TOTAL THYROXINE PLASMA-CONCENTRATION

被引：5
作者：
ABALAN, F
HOA, AHB
DUFRECHOU, N
ELLISON, W
RIGAL, F
PEREY, F
COMBOURIEU, I
BOURGEOIS, M
机构：
[1] UNIV BORDEAUX 1,ECOLE NATL SUPER CHIM PHYS BORDEAUX,PHYS INTERACT ONDES MAT LAB,F-33405 TALENCE,FRANCE
[2] CLIN PINS,PESSAC,FRANCE
来源：
HORMONE AND METABOLIC RESEARCH | 1991年 / 23卷 / 08期
关键词：
D O I：
10.1055/s-2007-1003713
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：404 / 405
页数：2
相关论文
共 50 条
[21]   PLASMA-CONCENTRATION OF FREE DRUG [J].
DURAN, JA ;
ABADIN, JA .
MEDICINA CLINICA, 1988, 91 (16) :618-620
[22]   MONITORING PLASMA-CONCENTRATION OF NORTRIPTYLINE [J].
KRAGHSORENSEN, P .
DANISH MEDICAL BULLETIN, 1985, 32 (01) :29-53
[23]   ASPIRIN - PLASMA-CONCENTRATION AND EFFECTS [J].
THIESSEN, JJ .
THROMBOSIS RESEARCH, 1983, :105-111
[24]   PLASMA-CONCENTRATION MONITORING OF AMINOGLYCOSIDES [J].
FOLLATH, F ;
WENK, M ;
VOZEH, S .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 :37-43
[25]   PLASMA-CONCENTRATION IN AN ELECTROMAGNETIC TRAP [J].
KOMAROV, AD ;
LAVRENTEV, OA ;
POTAPENKO, VA ;
SKIBENKO, AI ;
STEPANENKO, IA ;
FOMIN, IP .
HIGH TEMPERATURE, 1981, 19 (03) :453-457
[26]   EFFECT OF FUROSEMIDE ON PLASMA-CONCENTRATION AND BETA-BLOCKADE BY PROPRANOLOL [J].
CHIARIELLO, M ;
VOLPE, M ;
RENGO, F ;
TRIMARCO, B ;
VIOLINI, R ;
RICCIARDELLI, B ;
CONDORELLI, M .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1979, 26 (04) :433-436
[27]   EFFECT OF STORAGE ON THE PLASMA-CONCENTRATION OF CHLORPROMAZINE AND 6 OF ITS METABOLITES [J].
CHETTY, M ;
MILLER, R .
THERAPEUTIC DRUG MONITORING, 1991, 13 (04) :350-355
[28]   PLASMA-CONCENTRATION - EFFECT RELATIONSHIP OF METOPROLOL DURING AND AFTER PREGNANCY [J].
HOGSTEDT, S ;
RANE, A .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 44 (03) :243-246
[29]   PLASMA-CONCENTRATION AND ANTIHYPERTENSIVE EFFECT OF BETA-RECEPTOR BLOCKERS [J].
HITZENBERGER, G .
CARDIOLOGY, 1979, 64 :14-19
[30]   PLASMA-CONCENTRATION AND CLINICAL EFFECT IN IMIPRAMINE TREATMENT OF CHILDHOOD ENURESIS [J].
JORGENSEN, OS ;
LOBER, M ;
CHRISTIANSEN, J ;
GRAM, LF .
CLINICAL PHARMACOKINETICS, 1980, 5 (04) :386-393
12345